-10%

Elsevier's 2025 Intravenous Medications, 41st Edition

Name: Elsevier’s 2025 Intravenous Medications, 41st Edition
SKU: 9780443120404
Availability: PreOrder
ISBN: 9780443120404

Original price was: 62.49 €.Current price is: 56.24 €.

ISBN Number	9780443120404
Author Information	By Shelly Rainforth Collins, PharmD, BCGP
Copyright Year	2025
Edition Number	41
Format	Book
Format Size	152w x 229h (6.00″ x 9.00″)
Imprint	Elsevier
Page Count	1344
Publication Date	11-12-2024

Available on backorder

SKU: 9780443120404 Categories: Clinical medicine, Pharmacology, Pharmacology and pharmacotherapy Tag: no-bg

Description
Additional information

Elsevier's 2025 Intravenous Medications, 41st Edition

**Selected for Doody's Core Titles® 2024 with "Essential Purchase" designation in Pharmacology**

Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier's Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2025 edition are 16 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.

Key Features

Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference.
Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more.
Additional drug monographs are provided on the Evolve website.
Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks.
Blue-screened text calls attention to special circumstances not covered by Black Box Warnings.
Dosage and dilution charts within monographs provide quick summaries of essential clinical information.
Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds.
Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks.
NEW! Drug monographs for 16 newly approved drugs by the FDA include the most current information.
NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications.
NEW! Best practices guidelines for the preparation and administration of injectable drugs are provided from the National Coalition for IV Push Safety.

Author Information

By Shelly Rainforth Collins, PharmD, BCGP, President, Drug Information Consultants, Chesapeake, Virginia

******************

Elsevier's 2025 Intravenous Medications (41st Edition) is the leading reference guide for healthcare professionals who use intravenous (IV) medications in their clinical practice. Created by experts in the field, this book provides the most up-to-date information on more than 400 commonly used intravenous medications. The ability to rely on comprehensive, precise, and easy-to-navigate guidance makes this textbook a must-have for the training and practice of nurses, pharmacists, physicians, and other healthcare professionals.

Relevance and importance

Because intravenous therapy requires a high level of precision, safety, and knowledge, Elsevier's 2025 Intravenous Medications is a key resource for reducing the risk of medication errors. Treatment methods and new drugs change every year, and this edition offers comprehensive information that is aligned with the latest clinical guidelines, pharmacological research, and regulatory requirements.

Main features of the book

Complete Drug Catalog: The textbook contains detailed information on over 400 intravenous drugs, including new and commonly used drugs. Each drug is described in detail - from mechanisms of action and indications to recommendations for dilution and stability.

Systematic approach: Drugs are arranged alphabetically, making it easy to search and access information quickly. Tables are also included to allow easy reference for incompatibilities, interactions, and dosages.

Safety information: Special emphasis is placed on safety measures, such as warnings about allergic reactions, instructions for administration, and management of adverse events.

User-friendly format: The pages are organized to provide information in an easy-to-read format, including clear headings, subheadings, and highlighted key aspects of each medication.

Electronic access: Along with the print edition, the book offers access to an online platform where readers can find additional resources, updates, and interactive features.

Content

"Elsevier's 2025 Intravenous Medications" covers key topics such as:

Pharmacological properties of IV medications: Description of pharmacokinetics, pharmacodynamics and mechanism of action.

Dosage guidelines: Standardized recommendations for adults, children, and special populations (e.g., patients with renal or hepatic insufficiency).

Dilution and stability: Guidelines for the preparation and storage of drugs that ensure their effectiveness and safety.

Interactions and incompatibilities: Analysis of drug interactions, as well as factors that may compromise the stability of solutions.

Clinical application

The textbook is extremely useful for medical professionals in various fields, including hospitals, intensive wards, hospices and outpatient centers. It supports:

Nurses: Ensuring safe and effective administration of intravenous medications.

Pharmacists: Optimizing the therapeutic regimen by advising the medical team on dosages, interactions, and stability.

Doctors: Quick access to information on choosing appropriate treatment and minimizing the risk of adverse events.

Conclusion

Elsevier's 2025 Intravenous Medications is an indispensable tool for any clinical practice that involves intravenous therapy. This book combines scientific rigor with practical guidance, making it an essential resource for anyone involved in patient care. Whether you are a student, a recent graduate, or an experienced practitioner, it provides confidence and competence in the daily management of IV medications.